Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Polk

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
The Annals of Pharmacotherapy|July 29, 1998
Red man syndromeR E Polk
Drug Intelligence & Clinical Pharmacy|February 1, 1982
New drug evaluations: moxalactam (Moxam, Eli Lilly)R E Polk
The Journal of Antimicrobial Chemotherapy|April 1, 1991
Anaphylactoid reactions to glycopeptide antibioticsR E Polk
Pharmacotherapy|July 1, 1982
Third generation cephalosporins: possible impact upon pharmacy practiceR E Polk
The Annals of Pharmacotherapy|July 1, 1993
Comment: aminoglycoside dosing considerationsR E Polk
The American Journal of Medicine|November 30, 1989
Drug-drug interactions with ciprofloxacin and other fluoroquinolonesR E Polk
Bulletin of the New York Academy of Medicine|July 1, 1987
The role of the infectious diseases physician in monitoring antimicrobial use: a pharmacy perspectiveR E Polk
Annals of Internal Medicine|July 15, 1988
Norfloxacin and absorption of magnesium-aluminumM Noyes, R E Polk
American Journal of Hospital Pharmacy|June 1, 1981
Effects of cefazolin and moxalactam on serum chemistry values determined by autoanalyzerR E Polk, G H Stephens
American Journal of Hospital Pharmacy|July 1, 1980
Mall order tobramycin serum levels: low values caused by ticarcillinR E Polk, B J Kline
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
The Annals of Pharmacotherapy|July 29, 1998
Red man syndromeR E Polk
Drug Intelligence & Clinical Pharmacy|February 1, 1982
New drug evaluations: moxalactam (Moxam, Eli Lilly)R E Polk
The Journal of Antimicrobial Chemotherapy|April 1, 1991
Anaphylactoid reactions to glycopeptide antibioticsR E Polk
Pharmacotherapy|July 1, 1982
Third generation cephalosporins: possible impact upon pharmacy practiceR E Polk
The Annals of Pharmacotherapy|July 1, 1993
Comment: aminoglycoside dosing considerationsR E Polk
The American Journal of Medicine|November 30, 1989
Drug-drug interactions with ciprofloxacin and other fluoroquinolonesR E Polk
Bulletin of the New York Academy of Medicine|July 1, 1987
The role of the infectious diseases physician in monitoring antimicrobial use: a pharmacy perspectiveR E Polk
Annals of Internal Medicine|July 15, 1988
Norfloxacin and absorption of magnesium-aluminumM Noyes, R E Polk
American Journal of Hospital Pharmacy|June 1, 1981
Effects of cefazolin and moxalactam on serum chemistry values determined by autoanalyzerR E Polk, G H Stephens
American Journal of Hospital Pharmacy|July 1, 1980
Mall order tobramycin serum levels: low values caused by ticarcillinR E Polk, B J Kline
Pageof 6